Jian'er Jiedu granule alleviates acute lung injury via NOD2/NF-κB/NLRP3 axis: Network pharmacology, machine learning, and experimental validation.
BACKGROUND Acute lung injury (ALI) is a severe inflammatory disorder associated with high mortality. Jian'er Jiedu granule (JEJD), a formulation developed by Guangdong Provincial Hospital of Traditional Chinese Medicine, has shown promise in alleviating Omicron-related symptoms; however, its therapeutic effects on ALI...